Regenxbio (RGNX) Treasury Shares (2014 - 2025)

Regenxbio's Treasury Shares history runs 10 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 39.57% year-over-year to $2.8 million in Q4 2025; TTM through Dec 2025 was $2.8 million, a 39.57% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 39.57% from the prior year.
• Treasury Shares slipped to $2.8 million in Q4 2025 per RGNX's latest filing, from $2.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.0 million in Q2 2025 and bottomed at $254000.0 in Q1 2021.
• The 5-year median for Treasury Shares is $1.4 million (2023), against an average of $1.4 million.
• Across the five-year window, Treasury Shares surged 200.42% in 2023 and gained 17.13% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $277000.0 in 2021, then soared by 121.3% to $613000.0 in 2022, then surged by 113.54% to $1.3 million in 2023, then surged by 56.0% to $2.0 million in 2024, then soared by 39.57% to $2.8 million in 2025.
• Per Business Quant, the three latest RGNX Treasury Shares figures stand at $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $3.0 million (Q2 2025).